Biomarkers
Assist in the application of surrogate biological endpoints (i.e. biomarkers) to validate an agent’s mechanism of action (MOA) and relevance to clinical endpoints; sample collection training, biobanking, and assay performance
Genomics
Provide proprietary analytic applications for genomic, epigenomic and demographic inputs to establish and/or expand MOA claims (all-new IP discovered belongs to client) and differentiate responder/non-responder populations